Codexis Stock (NASDAQ:CDXS), Quotes and News Summary

Q: What sector and industry does Codexis (CDXS) operate in?

Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Codexis Stock (NASDAQ: CDXS) stock price, news, charts, stock research, profile.

Open	$3.610
Close	$3.650
Volume / Avg.	599.277K / 599.780K
Day Range	3.571 - 3.730
52 Wk Range	1.450 - 4.910
Market Cap	$258.241M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	3.83%
Days to Cover	6.87

Recent News

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Avi Kapoor

Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).

Akanksha Bakshi

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Codexis (CDXS) stock?

You can purchase shares of Codexis (NASDAQ: CDXS) through any online brokerage.

View our list of the best stock brokerages.

Who are Codexis's (CDXS) competitors?

Other companies in Codexis’s space includes: Harvard Bioscience (NASDAQ:HBIO), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR), Quanterix (NASDAQ:QTRX) and Conduit Pharmaceuticals (NASDAQ:CDT).

What is the target price for Codexis (CDXS) stock?

The latest price target for Codexis (NASDAQ: CDXS) was reported by Benchmark on Friday, May 3, 2024. The analyst firm set a price target for 9.00 expecting CDXS to rise to within 12 months (a possible 145.90% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Codexis (CDXS)?

The stock price for Codexis (NASDAQ: CDXS) is $3.66 last updated Today at May 14, 2024 at 9:29 AM EDT.

Does Codexis (CDXS) pay a dividend?

There are no upcoming dividends for Codexis.

When is Codexis (NASDAQ:CDXS) reporting earnings?

Codexis’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Codexis (CDXS) going to split?

There is no upcoming split for Codexis.

What sector and industry does Codexis (CDXS) operate in?

Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-